TORONTO, March 26, 2019 (GLOBE NEWSWIRE) -- PRESS RELEASE -- Aura Health Inc. has announced the appointment of Alain Dobkin to its board of directors, subject to regulatory approval. Dobkin is a private equity investor with more than 20 years of investment and advisory experience, including 13 years with Citigroup Investment Bank in New York and Tel Aviv. Additionally, he was the Director of Citigroup’s Israel Investment Bank, where he served as advisor on strategic mergers and acquisitions and equity and debt capital raising transactions from both public and private markets globally. Dobkin brings a wealth of experience in global and Israeli finance and M&A, having managed transactions with aggregate value of ~US$40 billion.
To make room for Dobkin, Chris Carl has volunteered to step down as president and from Aura’s board to focus on his role as CEO of DigiCrypts.
Daniel Cohen, Aura’s CEO, commented, “Alain brings significant pedigree to Aura’s board of directors both from a financial perspective and a knowledge of Israeli and European markets. As we continue to build out our asset base in Israel and Europe, Alain being situated in Tel Aviv will be a tremendous asset to our business. We wish the best of luck to Chris in his new endeavor.”
